Hyundai Pharmaceutical Co Ltd
KRX:004310

Watchlist Manager
Hyundai Pharmaceutical Co Ltd Logo
Hyundai Pharmaceutical Co Ltd
KRX:004310
Watchlist
Price: 11 700 KRW 1.65% Market Closed
Market Cap: ₩305.8B

Operating Margin

1.1%
Current
Declining
by 1%
vs 3-y average of 2.1%

Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.

Operating Margin
1.1%
=
Operating Income
₩2.1B
/
Revenue
₩185.9B

Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.

Operating Margin
1.1%
=
Operating Income
₩2.1B
/
Revenue
₩185.9B

Peer Comparison

Country Company Market Cap Operating
Margin
KR
Hyundai Pharmaceutical Co Ltd
KRX:004310
300.8B KRW
Loading...
US
Eli Lilly and Co
NYSE:LLY
964.8B USD
Loading...
US
Johnson & Johnson
NYSE:JNJ
547.9B USD
Loading...
CH
Roche Holding AG
SIX:ROG
268.4B CHF
Loading...
UK
AstraZeneca PLC
LSE:AZN
209.9B GBP
Loading...
CH
Novartis AG
SIX:NOVN
219B CHF
Loading...
DK
Novo Nordisk A/S
CSE:NOVO B
1.7T DKK
Loading...
US
Merck & Co Inc
NYSE:MRK
267.4B USD
Loading...
IE
Endo International PLC
LSE:0Y5F
218B USD
Loading...
US
Pfizer Inc
NYSE:PFE
149.5B USD
Loading...
FR
Sanofi SA
PAR:SAN
94.6B EUR
Loading...

Market Distribution

In line with most companies in Korea
Percentile
40th
Based on 2 615 companies
40th percentile
1.1%
Low
-163 055.6% — -2.2%
Typical Range
-2.2% — 6.8%
High
6.8% — 22 874.8%
Distribution Statistics
Korea
Min -163 055.6%
30th Percentile -2.2%
Median 2.7%
70th Percentile 6.8%
Max 22 874.8%

Hyundai Pharmaceutical Co Ltd
Glance View

Market Cap
305.8B KRW
Industry
Pharmaceuticals

Hyundai Pharmaceutical Co., Ltd. engages in the manufacturing and distribution of pharmaceutical products, health food drinks and medical equipment. The company is headquartered in Cheonan, Chungcheongnam-Do and currently employs 378 full-time employees. The firm mainly provides two categories of products: pharmaceuticals, including ophthalmological tablets, clopidogrel bisulfate, mirtazapine tablets and others, which are applied in the treatment of depressive disorder, hypertension, hemostatics and others, as well as healthcare food products, including vitamin products, calcium supplements and others. The company also provides dietary various beverages and medical equipment. The firm mainly distributes its products within domestic market. In addition, the Company also involves in the leasing business.

Intrinsic Value
5 072.47 KRW
Overvaluation 57%
Intrinsic Value
Price
What is Operating Margin?
Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.
How is Operating Margin calculated?

Operating Margin is calculated by dividing the Operating Income by the Revenue.

Operating Margin
1.1%
=
Operating Income
₩2.1B
/
Revenue
₩185.9B
What is Hyundai Pharmaceutical Co Ltd's current Operating Margin?

The current Operating Margin for Hyundai Pharmaceutical Co Ltd is 1.1%, which is below its 3-year median of 2.1%.

How has Operating Margin changed over time?

Over the last 3 years, Hyundai Pharmaceutical Co Ltd’s Operating Margin has decreased from 3.4% to 1.1%. During this period, it reached a low of -1% on May 31, 2025 and a high of 5.1% on May 31, 2023.

Back to Top